Tiny drops, big questions: new study tests steroid eye drops in preterm infants
NCT ID NCT05387941
First seen May 02, 2026 · Last updated Jun 19, 2026 · Updated 12 times
Summary
This study looked at how steroid eye drops are absorbed and broken down in premature babies who have an eye disease called retinopathy of prematurity (ROP). The goal was to understand the safety and how the medicine moves through the body. Eleven infants were enrolled, and researchers took small blood and saliva samples to measure the drug levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINOPATHY OF PREMATURITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sahlgrenska University Hospital
Gothenburg, Västra Götaland County, 41685, Sweden
-
Skåne University Hospital
Lund, Skåne County, 22185, Sweden
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.